Hey I am on Medial • 7m
Medical Microbiologist here. This field is actually expanding rapidly post-COVID. Many new funding opportunities. Some emerging areas to consider: Antimicrobial resistance Microbiome studies Pathogen genomics Vaccine development Look for labs working in these areas - they're likely to have funding.
•
Helixworks Technologies • 4m
Can Sequencing replace traditional diagnostics in India? Traditional diagnostics are slow. Culture and antibiotic resistance tests take days or even weeks to deliver results. This can be detrimental for patients suffering from sepsis or fever of unk
See MoreFinding my self 😶�... • 5m
In 2025, the sectors expected to see the most startup IPOs include: 1. Fintech: Leading with six companies, including Aye Finance and Pine Labs. 2. Quick Commerce: Significant growth anticipated, with major players likely to list. 3. Edtech: Co
See More•
Helixworks Technologies • 4m
Why qPCR & Phenotypic Testing Must Be Displaced – Part II If you ever want to understand the scale of a problem, look at how much it costs. Tuberculosis alone costs India, Africa, and Brazil 27 trillion INR a year in lost productivity and healthcare
See More•
SucSEED Ventures • 2m
Early Stage Investment Trends: A Summary of Startup Funding in India (14th-19th April) 33.4 million dollars were deployed across 13 promising Indian startups last week. The following are interesting patterns in the way investors have prioritized fun
See MoreHistory always repea... • 7m
🔥 Huge Controversy Arrest Bill gates 🔥 💡Understanding the #ArrestBillGates Controversy 1. What Happened? 🚀 The hashtag #ArrestBillGates recently trended on social media platforms like X (formerly Twitter). It was fueled by conspiracy theories
See More•
Faad Network • 6m
Meet the woman from IIT who sold her startup to Hindustan Unilever for 264 CR. 1. Born to a mother who worked as an officer with the Punjab government's healthcare department, Aarti would constantly wake up in the middle of the night for medical eme
See MoreDownload the medial app to read full posts, comements and news.